Yevgeniy Romin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yevgeniy Romin has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Amit Regev
Weill Cornell Medicine 2 Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology New York, New York
18 shared publications - Anne-Laure Flamar
Weill Cornell Medicine 2 Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology New York, New York
18 shared publications - Chien-Huan Weng
Weill Cornell Medicine 24 Department of Pharmacology and Sandra and Edward Meyer Cancer Center New York, NY
18 shared publications - Christopher R. Cabanski
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
18 shared publications - Daniel Hirschhorn
Weill Cornell Medicine 1 New York, NY
18 shared publications - Danny N. Khalil
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
18 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Video S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Volumetric visualization of interaction shown in Supplemental Video 1
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessVideo S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Volumetric visualization of interaction shown in Supplemental Video 1
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Video S1 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Time-lapse SDCM, at 20-minute intervals, of treated neutrophils engaged in DIP prestained with lipophilic membrane dye (magenta) in coculture with B16-YFP (green).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessVideo S1 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Time-lapse SDCM, at 20-minute intervals, of treated neutrophils engaged in DIP prestained with lipophilic membrane dye (magenta) in coculture with B16-YFP (green).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Complete gene list for 10 cell types (Related to Figure 4B)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Complete gene list for 10 cell types (Related to Figure 4B)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data Video 1b from Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
Confocal Z-stack image of cells treated with MEK inhibitor
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data Video 1b from Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
Confocal Z-stack image of cells treated with MEK inhibitor
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Figure S5 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Figure S5 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data Video 1a from Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
Confocal Z-stack image of cells treated with DMSO
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data Video 1a from Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
Confocal Z-stack image of cells treated with DMSO
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Figure S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Figure S3 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Complete differentially expressed gene list between CMI WT and CMI KO in neutrophils (Related to Figure 5I)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from IL10R Inhibition Induces Neutrophil Tumoricidal Activity
Complete differentially expressed gene list between CMI WT and CMI KO in neutrophils (Related to Figure 5I)